Back
Nomura Tax-Free USA Short Term ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Buy
57
STAX
Nomura Tax-Free USA Short Term ETF
Last Price:
$25.50
Seasonality Move:
0.73%
Sell
27
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.51
Seasonality Move:
-18.07%
Buy
57
Nomura Tax-Free USA Short Term ETF (STAX)
is a Buy
Is Nomura Tax-Free USA Short Term ETF a Buy, Sell or Hold?
-
The current Nomura Tax-Free USA Short Term ETF [STAX] share price is $25.50. The Score for STAX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
STAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.53. The Score for INKT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STAX Stock Price Chart
What is Nomura Tax-Free USA Short Term ETF's stock price today?
-
The Nomura Tax-Free USA Short Term ETF share price today is $25.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STAX is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
STAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.6 | Buy |
| Relative Strength Index (14 RSI): | 58.28 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.45 - 25.49) | Buy |
| Bollinger Bands (100): | (25.46 - 25.6) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 44.15 | Sell |
| Chaikin Money Flow: | -6795 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.47) | Sell |
| Bollinger Bands (100): | (12.26 - 15.22) | Sell |
STAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.48 | Buy |
| 20-day SMA: | 25.47 | Buy |
| 50-day SMA: | 25.49 | Buy |
| 200-day SMA: | 25.4 | Buy |
| 8-day EMA: | 10.07 | Buy |
| 20-day EMA: | 4.62 | Buy |
| 50-day EMA: | 1.96 | Buy |
| 200-day EMA: | 0.5 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.26 | Sell |
| 20-day SMA: | 11.59 | Sell |
| 50-day SMA: | 12.86 | Sell |
| 200-day SMA: | 11.87 | Sell |
| 8-day EMA: | 11.94 | Sell |
| 20-day EMA: | 12 | Sell |
| 50-day EMA: | 12.64 | Sell |
| 200-day EMA: | 12.22 | Sell |
Nomura Tax-Free USA Short Term ETF Earnings Growth & STAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Nomura Tax-Free USA Short Term ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||